The motor band sign in ALS: presentations and frequencies in a consecutive series of ALS patients.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 Nov 2019
Historique:
received: 31 05 2019
revised: 28 08 2019
accepted: 29 08 2019
pubmed: 16 9 2019
medline: 15 9 2020
entrez: 16 9 2019
Statut: ppublish

Résumé

The primary role of magnetic resonance imaging (MRI) in routine diagnostic work-up of motor neuron disease patients is currently still largely limited to exclusion of relevant non-degenerative pathologies. We here present an illustrative case of a 63-year-old woman with early stage Frontotemporal-Dementia-Amyotrophic-Lateral-Sclerosis (FTD-ALS) spectrum disorder showing a striking hypointense signal of the cortical band along the precentral gyrus, termed "motor band sign" (MBS). Based on this finding, we analysed the frequency of the MBS in clinical routine MRIs in a large consecutive series of ALS patients (MRIs available from 157 patients). MBS was present in 5% patients of the total series, but in 78% of patients where susceptibility-weighted images (SWI) were available. These findings suggest that the MBS is a recurrent finding in ALS, which can be identified even on clinical routine 3 T-MRI, and as part of more complex motor neuron syndromes, such as FTD-ALS. Moreover, they indicate that SWI sequences should be considered as part of the clinical routine MRI protocol in the diagnostic work-up of ALS patients.

Identifiants

pubmed: 31521959
pii: S0022-510X(19)30372-7
doi: 10.1016/j.jns.2019.116440
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116440

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Benjamin Roeben (B)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.

Carlo Wilke (C)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.

Benjamin Bender (B)

Department of Neuroradiology, University of Tübingen, Tübingen, Germany.

Ulf Ziemann (U)

Department of Neurology & Stroke, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.

Matthis Synofzik (M)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany. Electronic address: matthis.synofzik@uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH